DURECT Corp (NASDAQ:DRRX)

CAPS Rating: 2 out of 5

The Company is a pharmaceutical Company developing therapies for the treatment of chronic diseases and conditions with its proprietary drug formulations and delivery platform technologies.

Recs

0
Player Avatar Maribaza (26.67) Submitted: 11/22/2010 12:45:01 PM : Underperform Start Price: $2.82 DRRX Score: +78.23

26,48,3378,55,70

Featured Broker Partners


Advertisement